Literature DB >> 2566349

Evidence for co-transmitter role of neuropeptide Y in the pig spleen.

J M Lundberg1, A Rudehill, A Sollevi, B Hamberger.   

Abstract

1. The possible involvement of neuropeptide Y (NPY) in relation to noradrenaline (NA) and adenosine triphosphate (ATP) mechanisms in the sympathetic nervous control of the vascular tone and capsule contraction in the blood perfused pig spleen was investigated in vivo. 2. Local injections or infusions of NA, NPY and alpha-, beta-methylene ATP (mATP) caused vasoconstriction (perfusion pressure increase) and capsule contraction (increased venous blood flow). ATP only evoked vasodilatation. NPY was about 50 fold more potent than NA as a vasoconstrictor, and the NPY response was more long-lasting. Reserpine treatment did not change the effects of NPY. 3. Electrical stimulation of the splenic nerves in control animals caused a frequency-dependent, guanethidine-sensitive output of both NPY-like immunoreactivity (-LI) and NA, suggesting co-release. The output of NPY-LI relative to NA was enhanced at high frequency stimulation. Furthermore, alpha-adrenoceptor blockade by phentolamine enhanced both the output of NPY-LI and NA while inhibition of the neuronal uptake of NA with desipramine reduced the low frequency stimulation-evoked overflow of NPY-LI. Preganglionic denervation did not change the output of NPY-LI or NA. 4. Reserpine treatment reduced both the splenic content of NA and NPY-LI. Preganglionic denervation inhibited the reserpine-induced depletion of the NPY content but not of NA in terminal areas. The stimulation-evoked NPY overflow was markedly enhanced, especially at low-frequency stimulation after reserpine, and the plasma levels of NPY-LI in the venous effluent were then in the nmolar range (i.e. where exogenous NPY induced vasoconstriction). The perfusion-pressure increase upon stimulation in reserpine-treated, preganglionically-denervated animals was highly correlated (r = 0.91) to the NPY overflow. The functional 0.5 Hz responses were reduced after reserpine, while at higher frequencies the functional effects were of similar magnitude to controls but longer-lasting. 5. Tyramine induced a release of NA but not of NPY-LI. Furthermore, the increase in perfusion pressure induced by tyramine was absent after reserpine. 6. After tachyphylaxis to the vasoconstrictor effects of mATP, the nerve stimulation-evoked, functional response as well as the NA and NPY-LI overflow were unchanged. After reserpine treatment, both the perfusion-pressure increase and NPY-LI overflow to nerve stimulation were reduced after mATP tachyphylaxis. 7. In conclusion, release of NPY rather than ATP may explain the long-lasting, non-adrenergic, splenic functional responses in reserpinized animals upon sympathetic stimulation. However, NA is most likely the main splenic transmitter when low-frequency stimulation is used under control conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566349      PMCID: PMC1854405          DOI: 10.1111/j.1476-5381.1989.tb11868.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  Autoregulation of neuromuscular transmission in the guinea-pig saphenous artery.

Authors:  M Fujioka; D W Cheung
Journal:  Eur J Pharmacol       Date:  1987-07-09       Impact factor: 4.432

2.  Kruskal-Wallis test: BASIC computer program to perform nonparametric one-way analysis of variance and multiple comparisons on ranks of several independent samples.

Authors:  E Theodorsson-Norheim
Journal:  Comput Methods Programs Biomed       Date:  1986-08       Impact factor: 5.428

3.  Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications.

Authors:  J M Lundberg; T Hökfelt
Journal:  Prog Brain Res       Date:  1986       Impact factor: 2.453

4.  Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine.

Authors:  K Kirkpatrick; G Burnstock
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

5.  The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study.

Authors:  I Muramatsu
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

6.  A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent.

Authors:  G Burnstock; C Kennedy
Journal:  Circ Res       Date:  1986-03       Impact factor: 17.367

7.  Release of neuropeptide Y (NPY) induced by tyramine in the isolated vas deferens of rat.

Authors:  J T Cheng; C L Shen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

8.  A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation.

Authors:  G Burnstock; J J Warland
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

9.  Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.

Authors:  J Pernow; J M Lundberg; L Kaijser; P Hjemdahl; E Theodorsson-Norheim; A Martinsson; B Pernow
Journal:  Clin Physiol       Date:  1986-12

10.  Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.

Authors:  A Rudehill; M Olcén; A Sollevi; B Hamberger; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1987-12
View more
  6 in total

1.  Distribution and origin of neuropeptide Y-immunoreactive fibers in the penis of the rat.

Authors:  Y Carrillo; E Fernandez; W G Dail; G Walton
Journal:  Cell Tissue Res       Date:  1991-04       Impact factor: 5.249

2.  The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog.

Authors:  P G Withrington; N Ansari; R Croxton; G de Nucci; J R Vane
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

3.  Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders.

Authors:  H von Holst; A Rudehill; J M Lundberg
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.

Authors:  J M Lundberg; A Modin
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  A study of ATP as a sympathetic cotransmitter in human saphenous vein.

Authors:  L C Rump; I von Kügelgen
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

6.  Sympathetic vascular control of the pig nasal mucosa: adrenoceptor mechanisms in blood flow and volume control.

Authors:  J S Lacroix; J M Lundberg
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.